News

AllerGenis Begins Testing Patient Samples for Peanut Allergy Using Proprietary Epitope Mapping Technology June 24, 2020

AllerGenis Announces Presentations at EAACI Digital Congress 2020 June 4, 2020

AllerGenis CEO Jim Garner joined by Proactive at the Biotech Showcase 2020 in San Francisco January 14, 2020

AllerGenis to Present at the 38th Annual J.P. Morgan Healthcare Conference January 8, 2020

New Research Demonstrates Clinical Viability of Epitope Mapping Technology Platform for Food Allergy Diagnosis December 23, 2019

AllerGenis to Showcase Latest Research Breakthroughs at EAACI Congress 2019 May 31, 2019

AllerGenis Granted Rights to Develop and Market Its Precision Food Allergy Diagnostic Using Luminex xMAP® Technology January 16, 2019

AllerGenis' Food Allergy Diagnostic Assay Demonstrates Significant Accuracy for Predicting Patient Outcomes in Milk Oral Immunotherapy December 3, 2018

Mount Sinai and AllerGenis, LLC partner to bring novel, precision diagnostics to food allergy patients. October 30, 2018

New food allergy diagnostics company, AllerGenis, recently launched to deliver innovative diagnostic technology enabling more precise food allergy detection and patient management. September 24, 2018